Stay updated on Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study record content. Previous content including locations, institutions, and study details has been removed and replaced by a simple error page with only a Home link.
    Difference
    19%
    Check dated 2026-09-23T00:39:31.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's revision label was updated from Revision: v3.6.6 to Revision: v3.7.0, indicating a maintenance/upgrade of the ClinicalTrials.gov interface for this record. The study information and controls remain the same.
    Difference
    0.1%
    Check dated 2026-09-15T23:52:47.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6. This reflects a new version of the page without altering its substantive content.
    Difference
    0.1%
    Check dated 2026-09-01T20:04:29.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.5, replacing the previous v3.6.4. This indicates a minor update to the page's release/version metadata without changing the study content.
    Difference
    0.1%
    Check dated 2026-08-11T13:30:58.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page footer now lists a revision update from v3.6.3 to v3.6.4, indicating a new edition of the page. No substantive study content or data appears to be changed.
    Difference
    0.1%
    Check dated 2026-07-28T05:28:00.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a new internal release for the study page. This update does not modify the study details or eligibility criteria presented on the page.
    Difference
    0.1%
    Check dated 2026-07-06T18:18:05.000Z thumbnail image

Stay in the know with updates to Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.